tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SNYNF Stock Latest News

Sanofi’s Parisian HQ raided in French tax fraud probe, Le Monde reports
The FlySanofi’s Parisian HQ raided in French tax fraud probe, Le Monde reports
3d ago
SNY
Regeneron, Sanofi announce European Commission approval for Dupixent
PremiumThe Fly
Regeneron, Sanofi announce European Commission approval for Dupixent
3d ago
SNY
REGN
DarioHealth announces publication of study in JMIR on digital health platform
PremiumThe Fly
DarioHealth announces publication of study in JMIR on digital health platform
4d ago
SNY
DRIO
Texas AG sues Sanofi, Bristol Myers over alleged Plavix inefficacy
PremiumThe Fly
Texas AG sues Sanofi, Bristol Myers over alleged Plavix inefficacy
8d ago
BMY
SNY
CDC webpage says vaccines may cause autism, WSJ reports
PremiumThe Fly
CDC webpage says vaccines may cause autism, WSJ reports
8d ago
GSK
PFE
Oppenheimer pharmaceuticals analysts hold analyst/industry conference call
PremiumThe FlyOppenheimer pharmaceuticals analysts hold analyst/industry conference call
9d ago
SNY
Sanofi facility in France cited for quality control issues by ANSM
Premium
The Fly
Sanofi facility in France cited for quality control issues by ANSM
14d ago
SNY
FDA appoints Richard Pazdur as Director of CDER
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
17d ago
AZN
BMY
Perspective Therapeutics price target lowered to $13 from $14 at Oppenheimer
PremiumThe Fly
Perspective Therapeutics price target lowered to $13 from $14 at Oppenheimer
17d ago
SNY
CATX
Sanofi, Regeneron report all primary endpoints met in LIBERTY-AFRS-AIMS study
PremiumThe Fly
Sanofi, Regeneron report all primary endpoints met in LIBERTY-AFRS-AIMS study
21d ago
SNY
REGN
Regeneron, Sanofi announces presentation of Phase 3 trial of Dupixent
PremiumThe Fly
Regeneron, Sanofi announces presentation of Phase 3 trial of Dupixent
21d ago
SNY
REGN
Dianthus price target raised to $62 from $60 at Oppenheimer
PremiumThe Fly
Dianthus price target raised to $62 from $60 at Oppenheimer
22d ago
SNY
DNTH
Novavax transfers U.S. marketing authorization for Nuvaxovid to Sanofi
PremiumThe FlyNovavax transfers U.S. marketing authorization for Nuvaxovid to Sanofi
24d ago
SNY
NVAX
FDA moves to accelerate biosimilar development, lower drug costs
Premium
The Fly
FDA moves to accelerate biosimilar development, lower drug costs
29d ago
AZN
BMY
Sanofi’s New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment
Premium
Company Announcements
Sanofi’s New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment
30d ago
SNYNF
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications
PremiumCompany Announcements
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications
1M ago
REGN
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications Ahead
PremiumCompany Announcements
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications Ahead
1M ago
REGN
Sanofi’s Phase 2 Cancer Study Update: Implications for Investors
PremiumCompany Announcements
Sanofi’s Phase 2 Cancer Study Update: Implications for Investors
1M ago
SNYNF
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
PremiumThe Fly
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
1M ago
LLY
MRK
Sanofi assumed with a Buy at Jefferies
PremiumThe FlySanofi assumed with a Buy at Jefferies
1M ago
SNY
Morning Movers: Intel, Ford rise after earnings
Premium
The Fly
Morning Movers: Intel, Ford rise after earnings
1M ago
F
GD
Sanofi reports Q3 IRFS EPS EUR 2.30, up 2.2% reported
Premium
The Fly
Sanofi reports Q3 IRFS EPS EUR 2.30, up 2.2% reported
1M ago
SNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >